mAbs (mAbs)
Journal Descriptions
mAbs is a multidisciplinary, open access journal dedicated to the art and science of antibody research and development. The journal has a strong scientific and medical focus but serves a broad readership, including specialists in technology transfer, legal issues, investment, planning and the regulation of therapeutics. mAbs covers a range of topics, including: Engineering and selection of antibody therapeutics, including antibody-drug conjugates, multispecific andtibodies, and single-domain antibodies Machine learning and artificial intelligence applications Non-clinical studies of antibodies, such as mechanism of action studies, safety and efficacy studies in animals Manufacturing and formulation Regulatory review of antibody therapeutics Post-approval topics, such as markets mAbs accepts original research papers, brief reports, short communications, reviews, perspectives, commentaries, meeting reports, and article addenda.
mAbs (mAbs) is :-
-
International, Peer-Reviewed, Open Access, Refereed, antibody-drug conjugates, multispecific andtibodies, technology transfer, legal issues, investment, Manufacturing and formulation , Online or Print , Continuously Journal
- UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1942-0862, E-ISSN: 1942-0870, Established: 2009, Impact Factor: 5.6
- Provides Crossref DOI
-
Indexed in: Scopus, WoS
-
Not indexed in DOAJ, PubMed, UGC CARE
